Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 321 | MSDL | MORGAN STANLEY DIRECT LENDIN | Financial Services | 24,668.0 | $373K | 0.09% | -4K | -12.8% | $15.12 | +1.7% |
| 322 | — | CLIMB BIO INC | — | 28,602.0 | $373K | 0.09% | NEW | — | $13.04 | — |
| 323 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 10,714.0 | $372K | 0.09% | -451.0 | -4.0% | $34.74 | -14.7% |
| 324 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 10,806.0 | $371K | 0.09% | -3K | -21.7% | $34.38 | +6.9% |
| 325 | — | UPSTREAM BIO INC | — | 53,638.0 | $371K | 0.09% | +44K | +433.9% | $6.92 | — |
| 326 | IVVD | INVIVYD INC | Healthcare | 424,933.0 | $371K | 0.09% | +307K | +261.5% | $0.87 | +8.8% |
| 327 | JANX | JANUX THERAPEUTICS INC | Healthcare | 24,130.0 | $371K | 0.09% | +6K | +35.4% | $15.36 | +13.7% |
| 328 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 76,807.0 | $369K | 0.09% | +19K | +32.7% | $4.80 | +3.6% |
| 329 | PHVS | PHARVARIS N V | Healthcare | 10,651.0 | $368K | 0.09% | -635.0 | -5.6% | $34.58 | +4.8% |
| 330 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 20,012.0 | $368K | 0.09% | +12K | +137.1% | $18.37 | +34.4% |
| 331 | BLTE | BELITE BIO INC | Healthcare | 2,369.0 | $365K | 0.09% | +440.0 | +22.8% | $153.98 | +9.3% |
| 332 | — | NEWAMSTERDAM PHARMA COMPANY | — | 10,763.0 | $365K | 0.09% | +3K | +47.1% | $33.89 | — |
| 333 | ANL | ADLAI NORTYE LTD | Healthcare | 31,705.0 | $365K | 0.09% | NEW | — | $11.50 | +23.3% |
| 334 | EFT | EATON VANCE FLOATING RATE IN | Financial Services | 33,745.0 | $364K | 0.09% | -12K | -26.5% | $10.80 | -0.6% |
| 335 | AURA | AURA BIOSCIENCES INC | Healthcare | 51,045.0 | $362K | 0.08% | NEW | — | $7.10 | +9.6% |
| 336 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 7,093.0 | $360K | 0.08% | -9K | -56.1% | $50.75 | +16.2% |
| 337 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 4,050.0 | $360K | 0.08% | -4K | -50.1% | $88.78 | +21.5% |
| 338 | EYPT | EYEPOINT INC | Healthcare | 25,111.0 | $359K | 0.08% | +8K | +47.3% | $14.30 | -58.7% |
| 339 | STOK | STOKE THERAPEUTICS INC | Healthcare | 10,973.0 | $359K | 0.08% | +3K | +30.4% | $32.72 | +0.7% |
| 340 | ARVN | ARVINAS INC | Healthcare | 43,166.0 | $359K | 0.08% | +21K | +99.1% | $8.31 | +15.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%